Login to Your Account



Cypress Bails After All

Schizophrenia Drug Returns to BioLineRx; Phase IIb Next

By Jennifer Boggs


Friday, May 13, 2011
The licensing deal that spurred a hostile takeover attempt by disgruntled shareholders at Cypress Bioscience Inc. – and eventually led to this year's buyout of the San Diego-based firm by Ramius LLC and Royalty Partners – has come to an end.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription